Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCL8 | P10145 | 6/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.56 |
| ▸ | TTR | P02766 | 3/20 | 0.56 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.56 |
| ▸ | UGT1A9 | O60656 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.56 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.56 |
| ▸ | ALB | P02768 | 1/20 | 0.56 |
| ▸ | UGT1A6 | P19224 | 1/20 | 0.56 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.56 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.56 |
| ▸ | UGT1A7 | Q9HAW7 | 1/20 | 0.56 |
| ▸ | UGT1A10 | Q9HAW8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diclofenac SCHEMBL28275411 | 0.76 | PTGS2 (0.89) | CXCL8PTGS2TTRAKR1B10UGT1A9 | |
| SCHEMBL27588261 | 0.72 | CXCL8 (0.64) | CXCL8PTGS2TTRAKR1B10UGT1A9 | |
| Diclofenac SCHEMBL996716 | 0.72 | PTGS2 (1.00) | CXCL8PTGS2TTRAKR1B10UGT1A9 | |
| Diclofenac SCHEMBL2799 | 0.72 | PTGS2 (1.00) | CXCL8PTGS2TTRAKR1B10UGT1A9 | |
| Diclofenac SCHEMBL29354260 | 0.72 | PTGS2 (1.00) | CXCL8PTGS2TTRAKR1B10UGT1A9 | |
| SCHEMBL6243911 | 0.71 | CXCL8 (1.00) | CXCL8PTGS2TTRAKR1B10UGT1A9 | |
| SCHEMBL22981599 | 0.71 | PTGS2 (0.75) | CXCL8PTGS2TTRAKR1B10UGT1A9 | |
| Diclofenac SCHEMBL40785 | 0.71 | PTGS2 (0.97) | CXCL8PTGS2TTRAKR1B10UGT1A9 | |
| Diclofenac SCHEMBL3184302 | 0.71 | PTGS2 (0.97) | CXCL8PTGS2TTRAKR1B10UGT1A9 | |
| Diclofenac SCHEMBL22370200 | 0.71 | PTGS2 (0.97) | CXCL8PTGS2TTRAKR1B10UGT1A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088918-B2 | Noncardiotoxic pharmaceutical compounds | WILLIAMSBURG HOLDINGS LLC (US) | 2012-01-03 | — | — | US | disclosed |
| US-20060035863-A1 | Noncardiotoxic pharmaceutical compounds | B&G PARTNERS, LLC | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060035863-A1 | Noncardiotoxic pharmaceutical compounds | KCNN3, TNNI3, TNNT2 | CXCL8 3555/4885PTGS2 2779/4885TTR 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.